Terms: = Endocrine gland cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Treatment
23 results:
1. Case report: Sagliker syndrome in the patient with recurrent tertiary hyperparathyroidism due to intrathyroidal parathyroid carcinoma.
Salimkhanov R; Bondarenko E; Eremkina A; Bibik E; Kim E; Begova K; Kim I; Kuznetsov S; Mokrysheva N
Front Endocrinol (Lausanne); 2023; 14():1292993. PubMed ID: 38250739
[TBL] [Abstract] [Full Text] [Related]
2. Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7.
Heublein S; Pfisterer J; du Bois A; Anglesio M; Aminossadati B; Bhatti I; Sehouli J; Wimberger P; Schochter F; Hilpert F; Hillemanns P; Kalder M; Schroeder W; Mahner S; Burges A; Canzler U; Gropp-Meier M; Jackisch C; Harter P; Kommoss S; Marmé F
Lab Invest; 2024 Apr; 104(4):100321. PubMed ID: 38154497
[TBL] [Abstract] [Full Text] [Related]
3. Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-agent fibroblast growth factor receptor-specific inhibitors in pancreatic cancer.
Lin Q; Serratore A; Perri J; Roy Chaudhuri T; Qu J; Ma WW; Kandel ES; Straubinger RM
Br J Pharmacol; 2024 May; 181(9):1383-1403. PubMed ID: 37994108
[TBL] [Abstract] [Full Text] [Related]
4. Molecular biological analysis revealed a case of synchronous endometrial and ovarian cancer with different histological grade as metastatic ovarian cancer from endometrial cancer: Case report and review of literature.
Yumisashi R; Saito R; Togami S; Kobayashi Y; Kitazono I; Tanimoto A; Kobayashi H
J Obstet Gynaecol Res; 2023 Nov; 49(11):2766-2770. PubMed ID: 37604499
[TBL] [Abstract] [Full Text] [Related]
5. [Analysis of risk factors for recurrence of differentiated thyroid carcinoma after surgical resection combined with iodine-131 and TSH suppression therapy].
Ye T; Lai S; Cao B; Xu B; Wang R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 May; 37(5):370-374. PubMed ID: 37138400
[No Abstract] [Full Text] [Related]
6. Integrated Workflow for the Label-Free Isolation and Genomic Analysis of Single Circulating Tumor Cells in Pancreatic cancer.
Rupp B; Owen S; Ball H; Smith KJ; Gunchick V; Keller ET; Sahai V; Nagrath S
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887203
[TBL] [Abstract] [Full Text] [Related]
7. Novel insights into immunohistochemical analysis for diagnosing serous neoplasm of the pancreas: aquaporin 1, stereocilin, and transmembrane protein 255B.
Watase C; Fuse M; Ino Y; Naito C; Hiraoka N
Histopathology; 2021 Nov; 79(5):872-879. PubMed ID: 34288030
[TBL] [Abstract] [Full Text] [Related]
8. fgfr3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer.
Zhao J; Tan W; Zhang L; Liu J; Shangguan M; Chen J; Zhao B; Peng Y; Cui M; Zhao S
Biochem Pharmacol; 2021 Aug; 190():114536. PubMed ID: 33794187
[TBL] [Abstract] [Full Text] [Related]
9. Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation.
Pfitzinger PL; Fangmann L; Wang K; Demir E; Gürlevik E; Fleischmann-Mundt B; Brooks J; D'Haese JG; Teller S; Hecker A; Jesinghaus M; Jäger C; Ren L; Istvanffy R; Kühnel F; Friess H; Ceyhan GO; Demir IE
J Exp Clin Cancer Res; 2020 Dec; 39(1):289. PubMed ID: 33357230
[TBL] [Abstract] [Full Text] [Related]
10. treatment outcomes of percutaneous radiofrequency ablation versus adrenalectomy for adrenal metastases: a retrospective comparative study.
Liu B; Mo C; Wang W; Ye J; Jiang C; Xie X; Huang J; Huang G; Long H; Xie X
J Endocrinol Invest; 2020 Sep; 43(9):1249-1257. PubMed ID: 32166699
[TBL] [Abstract] [Full Text] [Related]
11. [Correlation of 41 loci of single nucleotide polymorphisms with testicular germ cell tumor].
Niu Y; Fuerhaiti S; Bi X; Yang F; Yuan S; Shi HZ; Han H; Chen P; Li CL
Zhonghua Nan Ke Xue; 2018 Jul; 24(7):602-607. PubMed ID: 30173442
[TBL] [Abstract] [Full Text] [Related]
12. treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
Wirth LJ; Tahara M; Robinson B; Francis S; Brose MS; Habra MA; Newbold K; Kiyota N; Dutcus CE; Mathias E; Guo M; Sherman SI; Schlumberger M
Cancer; 2018 Jun; 124(11):2365-2372. PubMed ID: 29656442
[TBL] [Abstract] [Full Text] [Related]
13. Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies.
Tyulyandina A; Harrison D; Yin W; Stepanova E; Kochenkov D; Solomko E; Peretolchina N; Daeyaert F; Joos JB; Van Aken K; Byakhov M; Gavrilova E; Tjulandin S; Tsimafeyeu I
Invest New Drugs; 2017 Apr; 35(2):127-133. PubMed ID: 27812884
[TBL] [Abstract] [Full Text] [Related]
14. Biomolecular characterization of adrenal gland tumors by means of SR-FTIR.
Dudala J; Bialas M; Surowka A; Bereza-Buziak M; Hubalewska-Dydejczyk A; Budzynski A; Pedziwiatr M; Kolodziej M; Wehbe K; Lankosz M
Analyst; 2015 Apr; 140(7):2101-6. PubMed ID: 25519296
[TBL] [Abstract] [Full Text] [Related]
15. Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas.
Cassol CA; Winer D; Liu W; Guo M; Ezzat S; Asa SL
Mod Pathol; 2014 Aug; 27(8):1050-62. PubMed ID: 24390213
[TBL] [Abstract] [Full Text] [Related]
16. Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival.
Oberic L; Viret F; Baey C; Ychou M; Bennouna J; Adenis A; Peiffert D; Mornex F; Pignon JP; Celier P; Berille J; Ducreux M
Radiat Oncol; 2011 Sep; 6():124. PubMed ID: 21943032
[TBL] [Abstract] [Full Text] [Related]
17. Hurthle cell neoplasms of thyroid in south-western region of Saudi Arabia.
Al-Shraim MM; Hussein MR; Musalam AO; Al-Ghandi T; Al-Zahramit H; Mahrouz AA; Abu-Eshy SA
West Afr J Med; 2010; 29(6):398-402. PubMed ID: 21465448
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer.
Cole C; Lau S; Backen A; Clamp A; Rushton G; Dive C; Hodgkinson C; McVey R; Kitchener H; Jayson GC
Cancer Biol Ther; 2010 Sep; 10(5):495-504. PubMed ID: 20595807
[TBL] [Abstract] [Full Text] [Related]
19. [S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma].
Takada J; Okuda K; Kenno S; Shimada S; Oba G; Shimokuni T; Aoki T; Hamada H
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2120-2. PubMed ID: 19106543
[TBL] [Abstract] [Full Text] [Related]
20. A hybrid machine learning-based method for classifying the Cushing's Syndrome with comorbid adrenocortical lesions.
Yang JY; Yang MQ; Luo Z; Ma Y; Li J; Deng Y; Huang X
BMC Genomics; 2008; 9 Suppl 1(Suppl 1):S23. PubMed ID: 18366613
[TBL] [Abstract] [Full Text] [Related]
[Next]
